Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219


Single-Cell Signature Explorer for comprehensive visualization of single cell signatures across scRNA-seq datasets.

Pont F, Tosolini M, Fournié JJ.

Nucleic Acids Res. 2019 Jul 11. pii: gkz601. doi: 10.1093/nar/gkz601. [Epub ahead of print]


[Control of lymphocyte activity by stress granules. New targets for immunotherapy ?]

Franchini DM, Lanvin O, Curdy N, Fournié JJ.

Med Sci (Paris). 2019 Jun-Jul;35(6-7):507-509. doi: 10.1051/medsci/2019109. Epub 2019 Jul 5. French. No abstract available.


Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Pizzolato G, Kaminski H, Tosolini M, Franchini DM, Pont F, Martins F, Valle C, Labourdette D, Cadot S, Quillet-Mary A, Poupot M, Laurent C, Ysebaert L, Meraviglia S, Dieli F, Merville P, Milpied P, Déchanet-Merville J, Fournié JJ.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11906-11915. doi: 10.1073/pnas.1818488116. Epub 2019 May 22.


PTMselect: optimization of protein modifications discovery by mass spectrometry.

Perchey RT, Tonini L, Tosolini M, Fournié JJ, Lopez F, Besson A, Pont F.

Sci Rep. 2019 Mar 12;9(1):4181. doi: 10.1038/s41598-019-40873-3.


Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma.

Rossi C, Gravelle P, Decaup E, Bordenave J, Poupot M, Tosolini M, Franchini DM, Laurent C, Morin R, Lagarde JM, Ysebaert L, Ligat L, Jean C, Savina A, Klein C, Céspedes AM, Perez-Galan P, Fournié JJ, Bezombes C.

Oncoimmunology. 2018 Dec 17;8(3):1554175. doi: 10.1080/2162402X.2018.1554175. eCollection 2019.


Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells.

Franchini DM, Lanvin O, Tosolini M, Patras de Campaigno E, Cammas A, Péricart S, Scarlata CM, Lebras M, Rossi C, Ligat L, Pont F, Arimondo PB, Laurent C, Ayyoub M, Despas F, Lapeyre-Mestre M, Millevoi S, Fournié JJ.

Cell Rep. 2019 Jan 2;26(1):94-107.e7. doi: 10.1016/j.celrep.2018.12.014.


The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.

Fournié JJ, Poupot M.

Front Immunol. 2018 Oct 26;9:2506. doi: 10.3389/fimmu.2018.02506. eCollection 2018. Review.


Profiling Immune Escape in Hodgkin's and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining.

Péricart S, Tosolini M, Gravelle P, Rossi C, Traverse-Glehen A, Amara N, Franchet C, Martin E, Bezombes C, Laurent G, Brousset P, Fournié JJ, Laurent C.

Cancers (Basel). 2018 Oct 31;10(11). pii: E415. doi: 10.3390/cancers10110415.


EBV infection determines the immune hallmarks of plasmablastic lymphoma.

Gravelle P, Péricart S, Tosolini M, Fabiani B, Coppo P, Amara N, Traverse-Gléhen A, Van Acker N, Brousset P, Fournie JJ, Laurent C.

Oncoimmunology. 2018 Jul 30;7(10):e1486950. doi: 10.1080/2162402X.2018.1486950. eCollection 2018.


Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.

Le Roy A, Prébet T, Castellano R, Goubard A, Riccardi F, Fauriat C, Granjeaud S, Benyamine A, Castanier C, Orlanducci F, Ben Amara A, Pont F, Fournié JJ, Collette Y, Mege JL, Vey N, Olive D.

Front Immunol. 2018 May 4;9:977. doi: 10.3389/fimmu.2018.00977. eCollection 2018.


DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status.

Grgurevic S, Montilla-Perez P, Bradbury A, Gilhodes J, Queille S, Pelofy S, Bancaud A, Filleron T, Ysebaert L, Récher C, Laurent G, Fournié JJ, Cazaux C, Quillet-Mary A, Hoffmann JS.

Haematologica. 2018 Jun;103(6):1038-1046. doi: 10.3324/haematol.2017.174243. Epub 2018 Mar 22.


Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.

Meraviglia S, Lo Presti E, Tosolini M, La Mendola C, Orlando V, Todaro M, Catalano V, Stassi G, Cicero G, Vieni S, Fourniè JJ, Dieli F.

Oncoimmunology. 2017 Jul 13;6(10):e1347742. doi: 10.1080/2162402X.2017.1347742. eCollection 2017.


Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.

Boissard F, Tosolini M, Ligat L, Quillet-Mary A, Lopez F, Fournié JJ, Ysebaert L, Poupot M.

Oncotarget. 2016 Nov 26;8(32):52225-52236. doi: 10.18632/oncotarget.13660. eCollection 2017 Aug 8.


IL-33-expanded human Vγ9Vδ2 T cells have anti-lymphoma effect in a mouse tumor model.

Duault C, Betous D, Bezombes C, Roga S, Cayrol C, Girard JP, Fournié JJ, Poupot M.

Eur J Immunol. 2017 Dec;47(12):2137-2141. doi: 10.1002/eji.201747093. Epub 2017 Sep 29.


BTN3A1-antibodies and phosphoantigens: TCRVγ9Vδ2 "see" the difference.

Franchini DM, Michelas M, Lanvin O, Poupot M, Fournié JJ.

Eur J Immunol. 2017 Jun;47(6):954-957. doi: 10.1002/eji.201747058.


Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Tosolini M, Pont F, Poupot M, Vergez F, Nicolau-Travers ML, Vermijlen D, Sarry JE, Dieli F, Fournié JJ.

Oncoimmunology. 2017 Feb 6;6(3):e1284723. doi: 10.1080/2162402X.2017.1284723. eCollection 2017.


Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies.

Gravelle P, Burroni B, Péricart S, Rossi C, Bezombes C, Tosolini M, Damotte D, Brousset P, Fournié JJ, Laurent C.

Oncotarget. 2017 Jul 4;8(27):44960-44975. doi: 10.18632/oncotarget.16680. Review.


Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment.

Betrian S, Ysebaert L, Heider KH, Delord JP, Fournié JJ, Quillet-Mary A.

Blood Cancer J. 2016 Nov 11;6(11):e496. doi: 10.1038/bcj.2016.106. No abstract available.


Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients.

Guggino G, Ciccia F, Di Liberto D, Lo Pizzo M, Ruscitti P, Cipriani P, Ferrante A, Sireci G, Dieli F, Fourniè JJ, Giacomelli R, Triolo G.

Clin Exp Immunol. 2016 Dec;186(3):277-283. doi: 10.1111/cei.12853. Epub 2016 Oct 21.


Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.

Tosolini M, Algans C, Pont F, Ycart B, Fournié JJ.

Oncoimmunology. 2016 May 19;5(7):e1188246. doi: 10.1080/2162402X.2016.1188246. eCollection 2016 Jul.


Poly(phosphorhydrazone) dendrimers: yin and yang of monocyte activation for human NK cell amplification applied to immunotherapy against multiple myeloma.

Poupot M, Turrin CO, Caminade AM, Fournié JJ, Attal M, Poupot R, Fruchon S.

Nanomedicine. 2016 Nov;12(8):2321-2330. doi: 10.1016/j.nano.2016.07.009. Epub 2016 Aug 3.


Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.

Boissard F, Laurent C, Ramsay AG, Quillet-Mary A, Fournié JJ, Poupot M, Ysebaert L.

Blood Cancer J. 2016 Jan 15;6:e381. doi: 10.1038/bcj.2015.108. No abstract available.


TCRVγ9 γδ T Cell Response to IL-33: A CD4 T Cell-Dependent Mechanism.

Duault C, Franchini DM, Familliades J, Cayrol C, Roga S, Girard JP, Fournié JJ, Poupot M.

J Immunol. 2016 Jan 1;196(1):493-502. doi: 10.4049/jimmunol.1500260. Epub 2015 Nov 25.


Cyclic dinucleotides modulate human T-cell response through monocyte cell death.

Tosolini M, Pont F, Verhoeyen E, Fournié JJ.

Eur J Immunol. 2015 Dec;45(12):3313-23. doi: 10.1002/eji.201545697. Epub 2015 Oct 15.


Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients.

Boissard F, Fournié JJ, Quillet-Mary A, Ysebaert L, Poupot M.

Blood Cancer J. 2015 Oct 2;5:e355. doi: 10.1038/bcj.2015.74. No abstract available.


Several immune escape patterns in non-Hodgkin's lymphomas.

Laurent C, Charmpi K, Gravelle P, Tosolini M, Franchet C, Ysebaert L, Brousset P, Bidaut A, Ycart B, Fournié JJ.

Oncoimmunology. 2015 Apr 2;4(8):e1026530. eCollection 2015 Aug.


L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo.

Lafouresse F, Bellard E, Laurent C, Moussion C, Fournié JJ, Ysebaert L, Girard JP.

Blood. 2015 Sep 10;126(11):1336-45. doi: 10.1182/blood-2015-02-626291. Epub 2015 Jul 10.


Radiolabelling rituximab with (99m)Tc in three steps procedure.

Fontan C, Bezombes C, Salabert AS, Costes J, Lopez R, Fournie JJ, Avet-Loiseau H, Coulais Y, Payoux P, Tafani M.

J Labelled Comp Radiopharm. 2015 Jun 15;58(7):274-80. doi: 10.1002/jlcr.3283. Epub 2015 May 27.


Nurse like cells: chronic lymphocytic leukemia associated macrophages.

Boissard F, Fournié JJ, Laurent C, Poupot M, Ysebaert L.

Leuk Lymphoma. 2015 May;56(5):1570-2. doi: 10.3109/10428194.2014.991731. Epub 2015 Feb 11.


Chicago 2014--30 years of γδ T cells.

Bonneville M, Chen ZW, Déchanet-Merville J, Eberl M, Fournié JJ, Jameson JM, Lopez RD, Massaia M, Silva-Santos B.

Cell Immunol. 2015 Jul;296(1):3-9. doi: 10.1016/j.cellimm.2014.11.001. Epub 2014 Nov 8.


The PPARα pathway in Vγ9Vδ2 T cell anergy.

Poupot M, Boissard F, Betous D, Bardouillet L, Fruchon S, L'Faqihi-Olive F, Pont F, Mekaouche M, Ingoure S, Sicard H, Dubreuilh G, Fournié JJ.

Cell Mol Biol Lett. 2014 Dec;19(4):649-58. doi: 10.2478/s11658-014-0218-0. Epub 2014 Nov 25.


Human monocyte recognition of adenosine-based cyclic dinucleotides unveils the A2a Gαs protein-coupled receptor tonic inhibition of mitochondrially induced cell death.

Tosolini M, Pont F, Bétous D, Ravet E, Ligat L, Lopez F, Poupot M, Poirot M, Pérouzel É, Tiraby G, Verhoeyen E, Fournié JJ.

Mol Cell Biol. 2015 Jan;35(2):479-95. doi: 10.1128/MCB.01204-14. Epub 2014 Nov 10.


Nonlesions, misdiagnoses, missed diagnoses, and other interpretive challenges in fish histopathology studies: a guide for investigators, authors, reviewers, and readers.

Wolf JC, Baumgartner WA, Blazer VS, Camus AC, Engelhardt JA, Fournie JW, Frasca S Jr, Groman DB, Kent ML, Khoo LH, Law JM, Lombardini ED, Ruehl-Fehlert C, Segner HE, Smith SA, Spitsbergen JM, Weber K, Wolfe MJ.

Toxicol Pathol. 2015 Apr;43(3):297-325. doi: 10.1177/0192623314540229. Epub 2014 Aug 11. Review.


Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes.

Decaup E, Duault C, Bezombes C, Poupot M, Savina A, Olive D, Fournié JJ.

Immunol Lett. 2014 Sep;161(1):133-7. doi: 10.1016/j.imlet.2014.05.011. Epub 2014 Jun 9.


Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma.

Gravelle P, Jean C, Familiades J, Decaup E, Blanc A, Bezombes-Cagnac C, Laurent C, Savina A, Fournié JJ, Laurent G.

Am J Pathol. 2014 Jan;184(1):282-95. doi: 10.1016/j.ajpath.2013.09.018. Epub 2013 Nov 11.


Curbing false discovery rates in interpretation of genome-wide expression profiles.

Ycart B, Pont F, Fournié JJ.

J Biomed Inform. 2014 Feb;47:58-61. doi: 10.1016/j.jbi.2013.09.004. Epub 2013 Sep 21.


Optimization of whole-body zebrafish sectioning methods for mass spectrometry imaging.

Nelson KA, Daniels GJ, Fournie JW, Hemmer MJ.

J Biomol Tech. 2013 Sep;24(3):119-27. doi: 10.7171/jbt.13-2403-002.


Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.

Laprevotte E, Voisin G, Ysebaert L, Klein C, Daugrois C, Laurent G, Fournie JJ, Quillet-Mary A.

J Immunol. 2013 Oct 1;191(7):3634-40. doi: 10.4049/jimmunol.1300187. Epub 2013 Aug 30.


The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells.

Kheirallah S, Fruchon S, Ysebaert L, Blanc A, Capilla F, Marrot A, Alsaati T, Frenois FX, Benhadji KA, Fournié JJ, Laurent G, Bezombes C.

Br J Pharmacol. 2013 Dec;170(7):1374-83. doi: 10.1111/bph.12351.


Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model.

Decaup E, Jean C, Laurent C, Gravelle P, Fruchon S, Capilla F, Marrot A, Al Saati T, Frenois FX, Laurent G, Klein C, Varoqueaux N, Savina A, Fournié JJ, Bezombes C.

Blood Cancer J. 2013 Aug 9;3:e131. doi: 10.1038/bcj.2013.32.


Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia.

Laprevotte E, Ysebaert L, Klein C, Valleron W, Blanc A, Gross E, Laurent G, Fournié JJ, Quillet-Mary A.

Leuk Res. 2013 Apr;37(4):440-6. doi: 10.1016/j.leukres.2012.11.015. Epub 2012 Dec 20.


What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Fournié JJ, Sicard H, Poupot M, Bezombes C, Blanc A, Romagné F, Ysebaert L, Laurent G.

Cell Mol Immunol. 2013 Jan;10(1):35-41. doi: 10.1038/cmi.2012.39. Epub 2012 Dec 17. Review.


First Report of Powdery Mildew Caused by Podosphaera pannosa on Prunus cerasus in France.

Hubert J, Fourrier C, Payen C, Fournié JL, Ioos R.

Plant Dis. 2012 Sep;96(9):1375. doi: 10.1094/PDIS-02-12-0218-PDN.


Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.

Coscia M, Vitale C, Peola S, Foglietta M, Rigoni M, Griggio V, Castella B, Angelini D, Chiaretti S, Riganti C, Guarini A, Drandi D, Ladetto M, Bosia A, Foà R, Battistini L, Boccadoro M, Fournié JJ, Massaia M.

Blood. 2012 Oct 18;120(16):3271-9. doi: 10.1182/blood-2012-03-417519. Epub 2012 Aug 29.


Innate predisposition to immune escape in follicular lymphoma cells.

Gravelle P, Jean C, Valleron W, Laurent G, Fournié JJ.

Oncoimmunology. 2012 Jul 1;1(4):555-556.


Comparative sensitivity of six scleractinian corals to temperature and solar radiation.

Fournie JW, Vivian DN, Yee SH, Courtney LA, Barron MG.

Dis Aquat Organ. 2012 Jun 13;99(2):85-93. doi: 10.3354/dao02459.


Phylogeny of fish-infecting Calyptospora species (Apicomplexa: Eimeriorina).

Whipps CM, Fournie JW, Morrison DA, Azevedo C, Matos E, Thebo P, Kent ML.

Parasitol Res. 2012 Sep;111(3):1331-42. doi: 10.1007/s00436-012-2969-8. Epub 2012 May 29.


Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.

Corre J, Labat E, Espagnolle N, Hébraud B, Avet-Loiseau H, Roussel M, Huynh A, Gadelorge M, Cordelier P, Klein B, Moreau P, Facon T, Fournié JJ, Attal M, Bourin P.

Cancer Res. 2012 Mar 15;72(6):1395-406. doi: 10.1158/0008-5472.CAN-11-0188. Epub 2012 Feb 2.


UVA-activated synthesis of metalloproteinases 1, 3 and 9 is prevented by a broad-spectrum sunscreen.

Jean C, Bogdanowicz P, Haure MJ, Castex-Rizzi N, Fournié JJ, Laurent G.

Photodermatol Photoimmunol Photomed. 2011 Dec;27(6):318-24. doi: 10.1111/j.1600-0781.2011.00627.x.


Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells.

Liffraud C, Quillet-Mary A, Fournié JJ, Laurent G, Ysebaert L.

Leuk Lymphoma. 2012 May;53(5):966-72. doi: 10.3109/10428194.2011.634041. Epub 2011 Dec 6.


Supplemental Content

Loading ...
Support Center